Navigation Links
Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
Date:6/22/2013

betes Federation. Diabetes Atlas, 5th Edition: Fact Sheet. 2012.
  • International Diabetes Federation. Diabetes Atlas, 5th Edition: What is Diabetes? http://www.idf.org/diabetesatlas/5e/what-is-diabetes.  Accessed on: June 18, 2013.
  • American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
  • *Empagliflozin is an investigational compound. Its safety and efficacy have not been established.

    (Logo: http://photos.prnewswire.com/prnh/20110825/DE57898LOGO )
    (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


    '/>"/>
    SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
    2. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
    3. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
    4. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
    5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
    6. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
    7. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
    8. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
    9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
    10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
    11. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, ... by Region ( North America , ... of the World) - Global Trends and Forecast to 2020", ... at USD 4.62 Billion in 2014 and is projected to ... 7.4% from 2015 to 2020. Browse 77 ...
    (Date:8/27/2015)... 2015  The Academy of Managed Care Pharmacy ... (FDA,s) draft guidance and proposed rule that calls ... bear a nonproprietary name with an FDA-designated suffix. ... decision from the FDA on the naming issue ... urging the agency to use the same nonproprietary ...
    (Date:8/27/2015)... ieCrowd™ today announced the achievement of ... the company,s supplemental oxygen delivery device, Smart Oxygen ... by ieCrowd,s subsidiary Smart Oxygen Solutions TM , ... oxygen based on level of activity.  The FDA ... Smart Oxygen device would require a series of ...
    Breaking Medicine Technology:Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
    ... 2011 The U.S. Food and Drug Administration today approved ... patients at risk of stroke due to clogged neck arteries ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The carotid arteries ... brain. The blood flow in the arteries can become partially ...
    ... May 6, 2011 On Thursday, the U.S. Food ... with progressive neuroendocrine tumors located in the pancreas (PNET) ... spread to other parts of the body (metastatic).   ... tumors found in the pancreas are slow-growing and rare. ...
    Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves New Treatment for Rare Type of Pancreatic Cancer 2
    (Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment ... position they are applying for, they are unable to pass the initial drug test ... drug testing policies in order to be able to hire long-term, skilled talent. (1) ...
    (Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... who might personally be struggling with chemical dependency, may be able to find ... Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. Focusing ...
    (Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, ... radiating pain resulting in shoulder pain, hip pain, neck pain, stiffness, muscle ... Engineering from the University of Illinois, and then went on to earn his title ...
    Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3
    ... impose a huge burden on industrialized societies, in terms ... costs related to back pain in the United States ... year. , But a systematic review of the literature ... of The Spine Journal finds exercise in ...
    ... The Sher Institutes of Reproductive Medicine (SIRM) announced today ... Plan that guarantees qualified IVF patients a baby ... medical fees. CGH is an acronym for Comparative Genomic ... egg or embryo prior to it being transferred to a ...
    ... (SCA), one of the country,s largest providers of specialty ... a joint venture relationship with Hawaii Pacific Health to ... downtown Honolulu.Under the terms of the partnership, SCA will ... at 550 South Beretania Street to a new location ...
    ... Calif., March 5 Grubb & Ellis Healthcare ... Medical Office Buildings Portfolio, an aggregate of four ... area. With buildings in Menomonee Falls, Milwaukee, ... 185,000 square feet of gross leaseable area. "This ...
    ... 5 Karen Ignagni, President and CEO of America,s ... the White House Health Care Summit:"We were honored to ... bringing together a broad range of policymakers and stakeholders ... President has initiated a transparent, inclusive reform process just ...
    ... ROCKVILLE, Md., March 5 Americans and nonprofit organizations ... of these circumstances, The Larry King Cardiac Foundation (LKCF), ... for individuals with no health insurance, has announced that ... 2009.In lieu of its annual black tie gala held ...
    Cached Medicine News:Health News:Clinical trials' review finds only exercise to prevent low-back problems 2Health News:New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden for Patients 2Health News:New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden for Patients 3Health News:Surgical Care Affiliates and Hawaii Pacific Health to Operate Surgery Center 2Health News:Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio 2Health News:Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio 3Health News:The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation 2Health News:The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation 3
    ... This therapeutic system ... the patient in mind. ... surgery and ongoing therapy, ... low-risk and effective therapy. ...
    All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
    ... not only one of the most modern lithotripters ... Apart from being designed for the treatment of ... tract, the MODULITH SLX can also be employed ... is equally suitable for the treatment of gallstones ...
    ... STORZ MEDICAL is the result of many ... of kidney stone lithotripsy and the successful ... met by orthopaedic apparatus for extracorporeal shock ... The MINILITH SL1 is characterized by its ...
    Medicine Products: